Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nature study: A novel family of antibiotics against tuberculosis and salmonella target pathways active in cancer.

29.11.2007
Researchers have discovered new ways to fight bacterial infections including extensively drug-resistant tuberculosis. The work will be published in the journal Nature on 29 November.

The research led by Dr. Jacques Neefjes from the Netherlands Cancer Institute, with collaboration of Dr. Tom Ottenhoff from the Leiden University Medical Center and Dr. Hermen Overkleeft from the Leiden University Institute of Chemistry, shows that pathways commonly found in cancer cells are also modified by pathogenic bacteria. It is likely that the discovery will lead to new drugs against cancer and tuberculosis.

The Dutch groups have developed chemical compounds which can greatly reduce the bacterial loads within infected human cells (such as Mycobacteria tuberculosis and Salmonella typhimurium). The chemical compounds they generated inhibit PKB/Akt1 enzymes in cells, enzymes which are also upregulated in various cancers. It appears that pathogenic bacteria seize control of PKB/Akt1 to evade immune degradation. Inhibiting the PKB/Akt1 enzyme thus forces the bacteria back into the degradation pathway to be eliminated.

PKB/Akt1 is the focus of cancer research at present since it has been shown to stimulate the growth of cancer cells. Discovering that bacteria utilize PKB/Akt1 in order to survive, sheds some light onto mechanisms that lead to cancer development following chronic bacterial infections in some patients.

“Many anti-cancer drugs originate from antibiotic discovery attempts. Pharmaceutical companies are currently developing specific PKB/Akt1 inhibitors. It is feasible that these inhibitors may well work against bacterial infections also”, says Dr. Jacques Neefjes.

This month, the World Health Organization (WHO) sounded the alarm because of a severe increase in multi and extensively drug-resistant (MDR and XDR) Mycobacterium tuberculosis infected countries. For MDR and XDR infected patients, current antibiotic therapy is inefficient or ineffective. New antibiotic therapies are therefore urgently needed.

This research was supported by the Netherlands Organization for Scientific Research (NWO), the Dutch Cancer Society (KWF) and an EEC network grant.

Frederique Melman | alfa
Further information:
http://www.nki.nl/Research/

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>